Education
About Us
Working with TipRanks
Follow Us
Thermo Fisher Scientific (TMO)
:TMO
TMO Stock Chart & Stats
Day’s Range― - ―
52-Week Range$385.46 - $627.88
Previous CloseN/A
Volume471.20K
Average Volume (3M)3.06M
Market Cap
$176.13B
Enterprise Value$183.26B
Total Cash (Recent Filing)$6.39B
Total Debt (Recent Filing)$35.23B
Price to Earnings (P/E)27.0
Beta0.78
Next Earnings
Oct 22, 2025EPS Estimate
5.51Next Dividend Ex-Date
Sep 15, 2025Dividend Yield0.35%
Share Statistics
EPS (TTM)5.36
Shares Outstanding377,612,120
10 Day Avg. Volume3,878,440
30 Day Avg. Volume3,060,288
Financial Highlights & Ratios
PEG Ratio4.64
Price to Book (P/B)4.01
Price to Sales (P/S)4.63
P/FCF Ratio27.35
Enterprise Value/Market Cap1.04
Enterprise Value/Revenue4.24
Enterprise Value/Gross Profit10.71
Enterprise Value/Ebitda16.08
Forecast
1Y Price Target
$543.89Price Target Upside16.61% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering18
Bulls Say, Bears Say
Bulls Say
Biopharma GrowthBiopharma customer growth improved to 5%, marking the strongest growth in 10 quarters and reflecting a positive demand outlook.
Financial PerformanceThermo Fisher reported improved financials with revenue increasing by 3.0% YoY and adjusted EPS slightly declining by 0.2% YoY, both exceeding Bloomberg consensus.
Investment PlansTMO announced a US$2bn investment plan in the US, including US$1.5bn in Capex, to capture growing opportunities in reshoring manufacturing.
Bears Say
Life Sciences R&DA confluence of headwinds could pressure life sciences R&D, an end market that broadly comprises 50% of Thermo's sales, longer than many expect.
Market DemandWeak performance in Chemical Analysis and Electron Microscopy due to low demand in China and A&G.
Organic Growth OutlookManagement lowered the long-term organic growth guidance, which indicates a more conservative outlook for future growth.
Thermo Fisher News
TMO FAQ
What was Thermo Fisher Scientific’s price range in the past 12 months?
Thermo Fisher Scientific lowest stock price was $385.46 and its highest was $627.88 in the past 12 months.
What is Thermo Fisher Scientific’s market cap?
Thermo Fisher Scientific’s market cap is $176.13B.
When is Thermo Fisher Scientific’s upcoming earnings report date?
Thermo Fisher Scientific’s upcoming earnings report date is Oct 22, 2025 which is in 76 days.
How were Thermo Fisher Scientific’s earnings last quarter?
Thermo Fisher Scientific released its earnings results on Jul 23, 2025. The company reported $5.36 earnings per share for the quarter, beating the consensus estimate of $5.226 by $0.134.
Is Thermo Fisher Scientific overvalued?
According to Wall Street analysts Thermo Fisher Scientific’s price is currently Undervalued.
Does Thermo Fisher Scientific pay dividends?
Thermo Fisher Scientific pays a Quarterly dividend of $0.43 which represents an annual dividend yield of 0.35%. See more information on Thermo Fisher Scientific dividends here
What is Thermo Fisher Scientific’s EPS estimate?
Thermo Fisher Scientific’s EPS estimate is 5.51.
How many shares outstanding does Thermo Fisher Scientific have?
Thermo Fisher Scientific has 377,612,120 shares outstanding.
What happened to Thermo Fisher Scientific’s price movement after its last earnings report?
Thermo Fisher Scientific reported an EPS of $5.36 in its last earnings report, beating expectations of $5.226. Following the earnings report the stock price went up 9.141%.
Which hedge fund is a major shareholder of Thermo Fisher Scientific?
Currently, no hedge funds are holding shares in TMO
Thermo Fisher Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$543.89 (16.61% Upside)
$543.89 (16.61% Upside)
Blogger Sentiment
Bullish
TMO Sentiment 70%
Sector Average 71%
Sector Average 71%
Hedge Fund Trend
Decreased
By 745.5K Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Very Positive
Last 7 Days ▲ 0.3%
Last 30 Days ▲ 3.9%
Last 30 Days ▲ 3.9%
News Sentiment
Neutral
Bullish news 59%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-25.18%
12-Months-Change
Fundamentals
Return on Equity
13.44%
Trailing 12-Months
Asset Growth
2.78%
Trailing 12-Months
Company Description
Thermo Fisher Scientific
Thermo Fisher Scientific Inc. provides life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and biopharma services in the North America, Europe, Asia-Pacific, and internationally. The company's Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery, and production of drugs and vaccines, as well as diagnosis of infections and diseases; and solutions include biosciences, genetic sciences, and bio production to pharmaceutical, biotechnology, agricultural, clinical, healthcare, academic, and government markets. Its Analytical Instruments segment provides instruments, consumables, software, and services for pharmaceutical, biotechnology, academic, government, environmental, and other research and industrial markets, as well as clinical laboratories. The company's Specialty Diagnostics segment offers liquid, ready-to-use, and lyophilized immunodiagnostic reagent kits, as well as calibrators, controls, protein detection assays, and instruments; immunodiagnostics develops, manufactures and markets complete bloodtest systems to support the clinical diagnosis and monitoring of allergy, asthma and autoimmune diseases; dehydrated and prepared culture media, collection and transport systems, instrumentation, and consumables; human leukocyte antigen typing and testing for organ transplant market; and healthcare products. Its Laboratory Products and Biopharma Services segment provides laboratory products, research and safety market channel, and pharma services and clinical research. It offers products and services through a direct sales force, customer-service professionals, electronic commerce, and third-party distributors under Thermo Scientific; Applied Biosystems; Invitrogen; Fisher Scientific; Unity Lab Services; and Patheon and PPD. Thermo Fisher Scientific Inc. was founded in 1956 and is headquartered in Waltham, Massachusetts.
TMO Earnings Call
Q2 2025
0:00 / 0:00
Earnings Call Sentiment|Neutral
The earnings call presented a balanced picture with strong revenue growth and operational performance, supported by strategic innovation and increased guidance. However, challenges remain in specific segments like academic, industrial, and diagnostics due to external factors such as tariffs and market hesitancy.View all TMO earnings summariesTMO Revenue Breakdown
54.01% Laboratory Products and Biopharma Services
22.46% Life Sciences Solutions
17.40% Analytical Instruments
10.52% Specialty Diagnostics
TMO Stock 12 Month Forecast
Average Price Target
$543.89
▲(16.61% Upside)
Technical Analysis
Ownership Overview
0.12% Insiders
24.44% Mutual Funds
1.50% Other Institutional Investors
53.98% Public Companies and Individual Investors